Thank you to the Good Doctor who originally posted this.
"Mr Paterson says he will “know either way” by the end of March if the company (ASX:AHZ) has a partner that will take the lead financially for the drug development business."
https://unauthorised investment advice/health/med...r-profit-after-near-death-experience-says-ceo
Very very exciting. The funds this could attract will be put to brilliant use accelerating the sale of the company's ADAPT products across the world and also in the development of our 3D vascular patch (which I believe will be used in surgeries for the femoral artery...)
Admedus Immunotherapy Deal
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.04 |
Change
-0.110(0.73%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $53.31K | 3.509K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 43 | $15.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.18 | 182 | 3 |
View Market Depth
| Last trade - 13.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |